Literature DB >> 18452957

Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice.

Astrid K Stoker1, Svetlana Semenova, Athina Markou.   

Abstract

The aversive aspects of nicotine withdrawal are powerful motivational forces contributing to the tobacco smoking habit. We evaluated measures of affective and somatic aspects of nicotine withdrawal in C57BL/6J and BALB/cByJ mice. Nicotine withdrawal was induced by termination of chronic nicotine delivery through osmotic minipumps or precipitated with the nicotinic acetylcholine receptor (nAChR) antagonists mecamylamine or dihydro-beta-erythroidine (DHbetaE). A rate-independent discrete-trial intracranial self-stimulation threshold procedure was used to assess brain reward function. Anxiety-like behavior and sensorimotor gating were assessed in the light-dark box and prepulse inhibition (PPI) tests, respectively. Acoustic startle response and somatic signs of withdrawal were also evaluated. Spontaneous nicotine withdrawal after 14-day exposure to 10-40 mg/kg/day nicotine induced no alterations in anxiety-like behavior, startle reactivity, PPI, or somatic signs in either strain, and no changes in thresholds in C57BL/6J mice. Extended 28-day exposure to 40 mg/kg/day nicotine induced threshold elevations, increased somatic signs, and anxiety-like behavior 24 h post-nicotine in C57BL/6J mice; thresholds returned to baseline levels by day 4 in nicotine-exposed mice. Mecamylamine or DHbetaE administration induced threshold elevations in nicotine-exposed C57BL/6J mice compared with saline-exposed mice. In conclusion, administration of relatively high nicotine doses over prolonged periods of time induces both the affective and somatic aspects of spontaneous nicotine withdrawal in the mouse, while exposure to nicotine for shorter periods of time is sufficient for nAChR antagonist-precipitated nicotine withdrawal. The current study is one of the first to demonstrate reward deficits associated with both spontaneous and nAChR antagonist-precipitated nicotine withdrawal in C57BL/6J mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452957      PMCID: PMC2496875          DOI: 10.1016/j.neuropharm.2008.03.013

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  74 in total

1.  Nicotine abstinence in the mouse.

Authors:  R Isola; V Vogelsberg; T A Wemlinger; N H Neff; M Hadjiconstantinou
Journal:  Brain Res       Date:  1999-12-11       Impact factor: 3.252

Review 2.  Co-factors for smoking and evolutionary psychobiology.

Authors:  C S Pomerleau
Journal:  Addiction       Date:  1997-04       Impact factor: 6.526

3.  Intermale aggression and dark/light preference in ten inbred mouse strains.

Authors:  P V Guillot; G Chapouthier
Journal:  Behav Brain Res       Date:  1996-05       Impact factor: 3.332

4.  Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.

Authors:  A Castañé; E Valjent; C Ledent; M Parmentier; R Maldonado; O Valverde
Journal:  Neuropharmacology       Date:  2002-10       Impact factor: 5.250

5.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

6.  Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats.

Authors:  Amanda A Harrison; Fabrizio Gasparini; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2001-12-18       Impact factor: 4.530

7.  Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms.

Authors:  B E Hildebrand; G G Nomikos; C Bondjers; M Nisell; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1997-02       Impact factor: 4.530

8.  Cocaine and SKF-82958 potentiate brain stimulation reward in Swiss-Webster mice.

Authors:  Brian Gilliss; C J Malanga; Jeanne O Pieper; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2002-07-13       Impact factor: 4.530

9.  Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity.

Authors:  D R Helton; D L Modlin; J P Tizzano; K Rasmussen
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 10.  The scientific case that nicotine is addictive.

Authors:  I P Stolerman; M J Jarvis
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

View more
  45 in total

1.  Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal.

Authors:  Astrid K Stoker; Berend Olivier; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2011-12-03       Impact factor: 4.530

Review 2.  Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

Authors:  F Scott Hall; Athina Markou; Edward D Levin; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

3.  Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice.

Authors:  Astrid K Stoker; Berend Olivier; Athina Markou
Journal:  Behav Genet       Date:  2011-10-19       Impact factor: 2.805

4.  Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline.

Authors:  Jill R Turner; Laura M Castellano; Julie A Blendy
Journal:  Nicotine Tob Res       Date:  2010-11-22       Impact factor: 4.244

5.  Both GABA(B) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats.

Authors:  Styliani Vlachou; Neil E Paterson; Sebastien Guery; Klemens Kaupmann; Wolfgang Froestl; Deboshri Banerjee; M G Finn; Athina Markou
Journal:  Eur J Pharmacol       Date:  2011-01-22       Impact factor: 4.432

6.  The group II metabotropic glutamate receptor agonist LY379268 reduces toluene-induced enhancement of brain-stimulation reward and behavioral disturbances.

Authors:  Ming-Huan Chan; Yi-Ling Tsai; Mei-Yi Lee; Astrid K Stoker; Athina Markou; Hwei-Hsien Chen
Journal:  Psychopharmacology (Berl)       Date:  2015-06-06       Impact factor: 4.530

Review 7.  Negative affective states and cognitive impairments in nicotine dependence.

Authors:  F Scott Hall; Andre Der-Avakian; Thomas J Gould; Athina Markou; Mohammed Shoaib; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-06-06       Impact factor: 8.989

8.  Nicotine withdrawal-induced inattention is absent in alpha7 nAChR knockout mice.

Authors:  K K Higa; A Grim; M E Kamenski; J van Enkhuizen; X Zhou; K Li; J C Naviaux; L Wang; R K Naviaux; M A Geyer; A Markou; J W Young
Journal:  Psychopharmacology (Berl)       Date:  2017-02-28       Impact factor: 4.530

9.  Reward sensitization: effects of repeated nicotine exposure and withdrawal in mice.

Authors:  Monica R F Hilario; Jill R Turner; Julie A Blendy
Journal:  Neuropsychopharmacology       Date:  2012-07-25       Impact factor: 7.853

10.  Sarcosine attenuates toluene-induced motor incoordination, memory impairment, and hypothermia but not brain stimulation reward enhancement in mice.

Authors:  Ming-Huan Chan; Shiang-Sheng Chung; Astrid K Stoker; Athina Markou; Hwei-Hsien Chen
Journal:  Toxicol Appl Pharmacol       Date:  2012-10-12       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.